JENNA SANDERS: Open Payments
NPI 1407295355 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 28 payments from 13 companies in 2025. Trend: 2023 $273 · 2024 $135 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $82 |
| PFIZER INC. | 4 | $68 |
| Novo Nordisk Inc | 4 | $67 |
| GlaxoSmithKline, LLC. | 4 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| ABBVIE INC. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Exact Sciences Corporation | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: LEQVIO, Wegovy, REPATHA, NURTEC ODT, TRELEGY ELLIPTA, ELIQUIS, Kerendia, XIFAXAN.
Industry payments across MO — which companies pay providers there.
